Note: This study is for semaglutide (Wegovy), but similar patterns are expected for GLP-1 class medications including tirzepatide (Zepbound)
21,22 Although clear protective benefits in diabetic retinopathy development and impact on disease progression remain under investigation, GLP-1RAs have been shown to reduce complications from chronic diabetes, such as retinal vein occlusion and cardiovascular disease
Quick Answer: Most patients experience noticeable appetite suppression within one to four weeks of starting tirzepatide, with effects becoming more pronounced as doses are gradually increased
Glutathione is generally very well tolerated
Asked to comment, session moderator Diane L
18,19 Inadequate energy spending together with excessive energy intake and storage induces obesity, which causes gain of weight